1
|
Lammers RJM, Tsachouridis G, Andersson MK, Dormeus S, Ekerhult TO, Frankiewicz M, Gunn CJ, Matuszewski M, de Mooij KL, Schroeder RPJ, Wyndaele MIA, Xing Z, De Kort LMO, de Graaf P. What should be next in lifelong posterior hypospadias: Conclusions from the 2023 ERN eUROGEN and EJP-RD networking meeting. Neurourol Urodyn 2024; 43:1097-1103. [PMID: 38289328 DOI: 10.1002/nau.25305] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/03/2023] [Accepted: 10/04/2023] [Indexed: 02/01/2024]
Abstract
BACKGROUND A congenital disease is for life. Posterior hypospadias, the severe form of hypospadias with a penoscrotal, scrotal, or perineal meatus, is a challenging condition with a major impact on lifelong quality of life. AIM Our network meeting is aimed to identify what is currently missing in the lifelong treatment of posterior hypospadias, to improve care, quality of life, and awareness for these patients. METHODS The network meeting "Lifelong Posterior Hypospadias" in Utrecht, The Netherlands was granted by the European Joint Programme on Rare Diseases-Networking Support Scheme. There was a combination of interactive sessions (hackathons) and lectures. This paper can be regarded as the last phase of the hackathon. RESULTS Surgery for hypospadias remains challenging and complications may occur until adulthood. Posterior hypospadias affects sexual function, fertility, and hormonal status. Transitional care from childhood into adulthood is currently insufficiently established. Patients should be more involved in defining desired treatment approach and outcome measures. For optimal outcome evaluation standardization of data collection and registration at European level is necessary. Tissue engineering may provide a solution to the shortage of healthy tissue in posterior hypospadias. For optimal results, cooperation between basic researchers from different centers, as well as involving clinicians and patients is necessary. CONCLUSIONS To improve outcomes for patients with posterior hypospadias, patient voices should be included and lifelong care by dedicated healthcare professionals guaranteed. Other requirements are joining forces at European level in uniform registration of outcome data and cooperation in basic research.
Collapse
Affiliation(s)
- Rianne J M Lammers
- Department of Urology, University Medical Center Groningen, Groningen, The Netherlands
| | - George Tsachouridis
- Department of Urology, University Medical Center Utrecht, Utrecht, The Netherlands
- Department of Pediatric Urology, Wilhemina Kinderziekenhuis, Utrecht, The Netherlands
- Regenerative Medicine Center Utrecht, Utrecht, The Netherlands
| | - Marie K Andersson
- Department of Pediatric Surgery, Sahlgrenska Academy, Women's and Children's Health, Queen Silvia's Children's Hospital, Gothenburg, Sweden
| | - Sarah Dormeus
- Department of Urology, University Medical Center Utrecht, Utrecht, The Netherlands
| | - Teresa O Ekerhult
- Department of Urology, Sahlgrenska University Hospital, Gothenburg, Sweden
| | | | - Callum J Gunn
- Department of Bioethics and Health Humanities, Julius Center, University Medical Center Utrecht, Utrecht, The Netherlands
| | | | - Keetje L de Mooij
- Department of Pediatric Urology, Wilhemina Kinderziekenhuis, Utrecht, The Netherlands
| | - Rogier P J Schroeder
- Department of Pediatric Urology, Wilhemina Kinderziekenhuis, Utrecht, The Netherlands
| | - Michel I A Wyndaele
- Department of Urology, University Medical Center Utrecht, Utrecht, The Netherlands
| | - Zhentao Xing
- Department of Urology, University Medical Center Utrecht, Utrecht, The Netherlands
- Regenerative Medicine Center Utrecht, Utrecht, The Netherlands
| | - Laetitia M O De Kort
- Department of Urology, University Medical Center Utrecht, Utrecht, The Netherlands
- Regenerative Medicine Center Utrecht, Utrecht, The Netherlands
| | - Petra de Graaf
- Department of Urology, University Medical Center Utrecht, Utrecht, The Netherlands
- Regenerative Medicine Center Utrecht, Utrecht, The Netherlands
| |
Collapse
|
2
|
Buchmann S, Enrico A, Holzreuter MA, Reid M, Zeglio E, Niklaus F, Stemme G, Herland A. Probabilistic cell seeding and non-autofluorescent 3D-printed structures as scalable approach for multi-level co-culture modeling. Mater Today Bio 2023; 21:100706. [PMID: 37435551 PMCID: PMC10331311 DOI: 10.1016/j.mtbio.2023.100706] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/03/2023] [Revised: 06/13/2023] [Accepted: 06/15/2023] [Indexed: 07/13/2023] Open
Abstract
To model complex biological tissue in vitro, a specific layout for the position and numbers of each cell type is necessary. Establishing such a layout requires manual cell placement in three dimensions (3D) with micrometric precision, which is complicated and time-consuming. Moreover, 3D printed materials used in compartmentalized microfluidic models are opaque or autofluorescent, hindering parallel optical readout and forcing serial characterization methods, such as patch-clamp probing. To address these limitations, we introduce a multi-level co-culture model realized using a parallel cell seeding strategy of human neurons and astrocytes on 3D structures printed with a commercially available non-autofluorescent resin at micrometer resolution. Using a two-step strategy based on probabilistic cell seeding, we demonstrate a human neuronal monoculture that forms networks on the 3D printed structure and can establish cell-projection contacts with an astrocytic-neuronal co-culture seeded on the glass substrate. The transparent and non-autofluorescent printed platform allows fluorescence-based immunocytochemistry and calcium imaging. This approach provides facile multi-level compartmentalization of different cell types and routes for pre-designed cell projection contacts, instrumental in studying complex tissue, such as the human brain.
Collapse
Affiliation(s)
- Sebastian Buchmann
- Division of Nanobiotechnology, KTH Royal Institute of Technology, Tomtebodavägen 23a, 171 65, Solna, Sweden
- AIMES – Center for the Advancement of Integrated Medical and Engineering Sciences, Department of Neuroscience, Karolinska Institute, 17177, Stockholm, Sweden
| | - Alessandro Enrico
- Division of Micro and Nanosystems, KTH Royal Institute of Technology, Malvinas väg 10, 100 44, Stockholm, Sweden
- Synthetic Physiology lab, Department of Civil Engineering and Architecture, University of Pavia, Via Ferrata 3, 27100, Pavia, Italy
| | - Muriel Alexandra Holzreuter
- AIMES – Center for the Advancement of Integrated Medical and Engineering Sciences, Department of Neuroscience, Karolinska Institute, 17177, Stockholm, Sweden
- Division of Micro and Nanosystems, KTH Royal Institute of Technology, Malvinas väg 10, 100 44, Stockholm, Sweden
| | - Michael Reid
- Department of Fiber and Polymer Technology, Wallenberg Wood Science Centre, KTH Royal Institute of Technology, Teknikringen 56-58, 100 44, Stockholm, Sweden
| | - Erica Zeglio
- Division of Nanobiotechnology, KTH Royal Institute of Technology, Tomtebodavägen 23a, 171 65, Solna, Sweden
- AIMES – Center for the Advancement of Integrated Medical and Engineering Sciences, Department of Neuroscience, Karolinska Institute, 17177, Stockholm, Sweden
| | - Frank Niklaus
- Division of Micro and Nanosystems, KTH Royal Institute of Technology, Malvinas väg 10, 100 44, Stockholm, Sweden
| | - Göran Stemme
- Division of Micro and Nanosystems, KTH Royal Institute of Technology, Malvinas väg 10, 100 44, Stockholm, Sweden
| | - Anna Herland
- Division of Nanobiotechnology, KTH Royal Institute of Technology, Tomtebodavägen 23a, 171 65, Solna, Sweden
- AIMES – Center for the Advancement of Integrated Medical and Engineering Sciences, Department of Neuroscience, Karolinska Institute, 17177, Stockholm, Sweden
| |
Collapse
|
3
|
Parfenov VA, Koudan EV, Krokhmal AA, Annenkova EA, Petrov SV, Pereira FDAS, Karalkin PA, Nezhurina EK, Gryadunova AA, Bulanova EA, Sapozhnikov OA, Tsysar SA, Liu K, Oosterwijk E, van Beuningen H, van der Kraan P, Granneman S, Engelkamp H, Christianen P, Kasyanov V, Khesuani YD, Mironov VA. Biofabrication of a Functional Tubular Construct from Tissue Spheroids Using Magnetoacoustic Levitational Directed Assembly. Adv Healthc Mater 2020; 9:e2000721. [PMID: 32809273 DOI: 10.1002/adhm.202000721] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/29/2020] [Revised: 07/06/2020] [Indexed: 12/15/2022]
Abstract
In traditional tissue engineering, synthetic or natural scaffolds are usually used as removable temporal support, which involves some biotechnology limitations. The concept of "scaffield" approach utilizing the physical fields instead of biomaterial scaffold has been proposed recently. In particular, a combination of intense magnetic and acoustic fields can enable rapid levitational bioassembly of complex-shaped 3D tissue constructs from tissue spheroids at low concentration of paramagnetic agent (gadolinium salt) in the medium. In the current study, the tissue spheroids from human bladder smooth muscle cells (myospheres) are used as building blocks for assembling the tubular 3D constructs. Levitational assembly is accomplished at low concentrations of gadolinium salts in the high magnetic field at 9.5 T. The biofabricated smooth muscle constructs demonstrate contraction after the addition of vasoconstrictive agent endothelin-1. Thus, hybrid magnetoacoustic levitational bioassembly is considered as a new technology platform in the emerging field of formative biofabrication. This novel technology of scaffold-free, nozzle-free, and label-free bioassembly opens a unique opportunity for rapid biofabrication of 3D tissue and organ constructs with complex geometry.
Collapse
Affiliation(s)
- Vladislav A. Parfenov
- Laboratory for Biotechnological Research “3D Bioprinting Solutions” Moscow 115409 Russia
- A. A. Baikov Institute of Metallurgy and Material Science Russian Academy of Sciences Moscow 119334 Russia
| | - Elizaveta V. Koudan
- Laboratory for Biotechnological Research “3D Bioprinting Solutions” Moscow 115409 Russia
| | - Alisa A. Krokhmal
- Department of Physics Lomonosov Moscow State University Moscow 119991 Russia
| | - Elena A. Annenkova
- Laboratory for Biotechnological Research “3D Bioprinting Solutions” Moscow 115409 Russia
| | - Stanislav V. Petrov
- Laboratory for Biotechnological Research “3D Bioprinting Solutions” Moscow 115409 Russia
| | | | - Pavel A. Karalkin
- P. A. Hertsen Moscow Oncology Research Center National Medical Research Radiological Center Moscow 125284 Russia
- I. M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University) Moscow 119991 Russia
| | - Elizaveta K. Nezhurina
- P. A. Hertsen Moscow Oncology Research Center National Medical Research Radiological Center Moscow 125284 Russia
| | - Anna A. Gryadunova
- Laboratory for Biotechnological Research “3D Bioprinting Solutions” Moscow 115409 Russia
| | - Elena A. Bulanova
- Laboratory for Biotechnological Research “3D Bioprinting Solutions” Moscow 115409 Russia
| | - Oleg A. Sapozhnikov
- Department of Physics Lomonosov Moscow State University Moscow 119991 Russia
| | - Sergey A. Tsysar
- Department of Physics Lomonosov Moscow State University Moscow 119991 Russia
| | - Kaizheng Liu
- Department of Urology Radboud University Medical Center Nijmegen 9102 The Netherlands
| | - Egbert Oosterwijk
- Department of Urology Radboud University Medical Center Nijmegen 9102 The Netherlands
| | - Henk van Beuningen
- Department of Experimental Rheumatology Radboud University Medical Center Nijmegen 9102 The Netherlands
| | - Peter van der Kraan
- Department of Experimental Rheumatology Radboud University Medical Center Nijmegen 9102 The Netherlands
| | - Sanne Granneman
- High Field Magnet Laboratory (HFML‐EMFL) Radboud University Toernooiveld 7 Nijmegen 9010 The Netherlands
| | - Hans Engelkamp
- High Field Magnet Laboratory (HFML‐EMFL) Radboud University Toernooiveld 7 Nijmegen 9010 The Netherlands
| | - Peter Christianen
- High Field Magnet Laboratory (HFML‐EMFL) Radboud University Toernooiveld 7 Nijmegen 9010 The Netherlands
| | - Vladimir Kasyanov
- Riga Stradins University Riga LV‐1007 Latvia
- Riga Technical University Riga LV‐1658 Latvia
| | - Yusef D. Khesuani
- Laboratory for Biotechnological Research “3D Bioprinting Solutions” Moscow 115409 Russia
| | - Vladimir A. Mironov
- Laboratory for Biotechnological Research “3D Bioprinting Solutions” Moscow 115409 Russia
- I. M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University) Moscow 119991 Russia
| |
Collapse
|